Stem cell transplantation in rheumatoid arthritis

References

• Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum 2001; 44(12)2746–2749
   PubMed Web of Science ®Google Scholar
• Snowden JA, Brooks PM, Biggs JC. Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol 1997; 99(1)9–22
   PubMed Web of Science ®Google Scholar
• Moore JJ, Snowden J, Pavletic S, et al. Hematopoietic stem cell transplantation for severe rheumatoid arthritis. Bone Marrow Transplant 2003; 32(Suppl 1)S53–S56
   Web of Science ®Google Scholar
• Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: A European perspective. Br J Haematol 2005; 128(4)432–459
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Koeller M, et al. New therapies for treatment of rheumatoid arthritis. Lancet 2007; 370(9602)1861–1874
   PubMed Web of Science ®Google Scholar
• van Bekkum DW, Bohre EP, Houben PF, Knaan-Shanzer S. Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 1989; 86(24)10090–10094
   PubMed Web of Science ®Google Scholar
• Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, van Bekkum DW. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8(5)333–338
   PubMed Web of Science ®Google Scholar
• van Bekkum DW. Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplant 2000; 25(4)357–364
   PubMed Web of Science ®Google Scholar
• van Bekkum DW. Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 2000; 20(1)10–16
   PubMed Web of Science ®Google Scholar
• van Bekkum DW. Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32(Suppl 1)S37–S39
   PubMed Web of Science ®Google Scholar
• Kamiya M, Sohen S, Yamane T, Tanaka S. Effective treatment of mice with type II collagen induced arthritis with lethal irradiation and bone marrow transplantation. J Rheumatol 1993; 20(2)225–230
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Nagata N, Hosaka N, et al. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells). Arthritis Rheum 1993; 36(2)263–268
   PubMed Web of Science ®Google Scholar
• Nelson JL, Torrez R, Louie FM, et al. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. J Rheumatol Suppl 1997; 48: 23–29
   PubMedGoogle Scholar
• Snowden JA, Kearney P, Kearney A, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998; 41(3)453–459
   PubMed Web of Science ®Google Scholar
• Lowenthal RM, Francis H, Gill DS. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant. J Rheumatol 2006; 33(4)812–813
   PubMed Web of Science ®Google Scholar
• McKendry RJ, Huebsch L, Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year follow-up. Arthritis Rheum 1996; 39(7)1246–1253
   PubMed Web of Science ®Google Scholar
• Snowden JA, Atkinson K, Kearney P, et al. Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient. Bone Marrow Transplant 1997; 20(1)71–73
   PubMed Web of Science ®Google Scholar
• Cooley HM, Snowden JA, Grigg AP, Wicks IP. Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum 1997; 40(9)1712–1715
   PubMed Web of Science ®Google Scholar
• Jondeau K, Job-Deslandre C, Bouscary D, et al. Remission of nonerosive polyarthritis associated with Sjogren's syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J Rheumatol 1997; 24(12)2466–2468
   PubMed Web of Science ®Google Scholar
• Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88(9)3621–3625
   PubMed Web of Science ®Google Scholar
• Snowden JA, Biggs JC, Milliken ST, et al. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum 1999; 42(11)2286–2292
   PubMed Web of Science ®Google Scholar
• Burt RK, Georganas C, Schroeder J, et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: Sustained response in two of four patients. Arthritis Rheum 1999; 42(11)2281–2285
   PubMed Web of Science ®Google Scholar
• van Laar JM, Verburg RJ, Fibbe WE, Breedveld FC. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: The Leiden experience. J Rheumatol Suppl 2001; 64: 25–27
   PubMedGoogle Scholar
• Bingham SJ, Snowden J, McGonagle D, et al. Autologous stem cell transplantation for rheumatoid arthritis-interim report of 6 patients. J Rheumatol Suppl 2001; 64: 21–24
   PubMedGoogle Scholar
• Pavletic SZ, Odell JR, Pirruccello SJ, et al. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: The University of Nebraska experience. J Rheumatol Suppl 2001; 64: 13–20
   PubMedGoogle Scholar
• Pavletic SZ, Klassen LW, Pope R, et al. Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis. J Rheumatol Suppl 2001; 64: 28–31
   PubMedGoogle Scholar
• Snowden JA, Biggs JC, Milliken ST, et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998; 22(11)1035–1041
   PubMed Web of Science ®Google Scholar
• Burt RK, Fassas A, Snowden J, et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28(1)1–12
   PubMed Web of Science ®Google Scholar
• Snowden JA, Passweg J, Moore JJ, et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR. J Rheumatol 2004; 31(3)482–488
   PubMed Web of Science ®Google Scholar
• Burt RK, Marmont A, Oyama Y, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54(12)3750–3760
   PubMed Web of Science ®Google Scholar
• Kapoor S, Wilson AG, Sharrack B, et al. Haemopoietic stem cell transplantation—an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology 2007; 12(3)179–191
   PubMed Web of Science ®Google Scholar
• Moore J, Brooks P, Milliken S, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46(9)2301–2309
   PubMed Web of Science ®Google Scholar
• Verburg RJ, Sont JK, van Laar JM. Reduction of joint damage in severe rheumatoid arthritis by high-dose chemotherapy and autologous stem cell transplantation. Arthritis Rheum 2005; 52(2)421–424
   PubMed Web of Science ®Google Scholar
• Teng YK, Verburg RJ, Sont JK, et al. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 2005; 52(8)2272–2276
   PubMed Web of Science ®Google Scholar
• Verburg RJ, Mahabali SD, Stiggelbout AM, et al. High dose chemotherapy and hematopoietic stem cell transplantation: A study of treatment preference in patients with rheumatoid arthritis and rheumatologists. J Rheumatol 2002; 29(8)1653–1658
   PubMed Web of Science ®Google Scholar
• Moore J, Ma D, Will R, et al. A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 34(3)241–247
   PubMed Web of Science ®Google Scholar
• Bingham S, Veale D, Fearon U, et al. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum 2002; 46(3)837–839
   PubMed Web of Science ®Google Scholar
• Verburg RJ, Flierman R, Sont JK, et al. Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T-cell infiltration. Ann Rheum Dis 2005; 64(10)1397–1405
   PubMed Web of Science ®Google Scholar
• Ponchel F, Verburg RJ, Bingham SJ, et al. Interleukin-7 deficiency in rheumatoid arthritis: Consequences for therapy-induced lymphopenia. Arthritis Res Ther 2005; 7(1)R80–R92
   Web of Science ®Google Scholar
• McColl G, Kohsaka H, Szer J, Wicks I. High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999; 131(7)507–509
   PubMed Web of Science ®Google Scholar
• McColl GJ, Szer J, Wicks IP. Sustained remission, possibly cure, of seronegative arthritis after high-dose chemotherapy and syngeneic hematopoietic stem cell transplantation. Arthritis Rheum 2005; 52(10)3322
   PubMed Web of Science ®Google Scholar
• van Oosterhout M, Verburg RJ, Levarht EW, et al. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: Poor response associated with persistence of host autoantibodies and synovial abnormalities. Ann Rheum Dis 2005; 64(12)1783–1785
   PubMed Web of Science ®Google Scholar
• Burt RK, Oyama Y, Verda L, et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004; 50(8)2466–2470
   PubMed Web of Science ®Google Scholar